SANDOZ APIXABAN SDZ

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 315db426c36d8bd6
Drug Approval Canada Name: SANDOZ APIXABAN SDZ
Product Name: SANDOZ APIXABAN SDZ
Status: Marketed
Status Date: 2022-09-22
Original Market Date: 2022-09-22
Din: 02489228
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF02 APIXABAN
Atc Name: b 01 af 02
Aig Number: 0153051001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

APIXABAN

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

315db426c36d8bd6

Type

Standard